Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNAP-IT: Neutrophil Activation Probe in ICU Patients
NCT02804854Phase 2Completed
- Sponsor
- University of Edinburgh
- Start
- Dec 2016
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in Lung disease, sponsored by University of Edinburgh. Primary endpoints: Reproducibility of Neutrophil Activation Probe signal at 2 years and Discriminant ability of Neutrophil Activation Probe signal in normal or abnormal lung segments at 2 years. Started Dec 2016; status: completed.
02
Conditions
Lung disease
Beyond the preview
Go deeper on NCT02804854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02804854.